TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 29,067 Value ($000) $1,111 Avg Close $32.52 Range $23.22 - $42.13

Q3 2025

Shares 42,505 Value ($000) $1,016 Avg Close $18.80 Range $14.36 - $28.69

Q4 2024

Shares 30,953 Value ($000) $539 Avg Close $17.69 Range $13.24 - $20.33

Q3 2024

Shares 61,695 Value ($000) $863 Avg Close $10.42 Range $7.72 - $15.36

Q2 2024

Shares 61,295 Value ($000) $504 Avg Close $6.73 Range $5.12 - $8.38

Q1 2024

Shares 48,594 Value ($000) $375 Avg Close $8.44 Range $7.11 - $10.27

Q4 2023

Shares 23,041 Value ($000) $207 Avg Close $7.28 Range $5.25 - $9.70

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	29,067	$1,111	$32.52	$23.22 - $42.13
Q3 2025	42,505	$1,016	$18.80	$14.36 - $28.69
Q4 2024	30,953	$539	$17.69	$13.24 - $20.33
Q3 2024	61,695	$863	$10.42	$7.72 - $15.36
Q2 2024	61,295	$504	$6.73	$5.12 - $8.38
Q1 2024	48,594	$375	$8.44	$7.11 - $10.27
Q4 2023	23,041	$207	$7.28	$5.25 - $9.70